CAR-T Cell Therapy Biomarkers: Kyoto U Discovery | AcademicJobs
Kyoto University researchers identify 4MD biomarkers predicting CAR-T therapy success in blood cancers, advancing precision oncology in Japan.
No reviews yet. Be the first to rate Itaru!
Itaru Kato serves as Senior Lecturer in the Graduate School of Medicine at Kyoto University, within the Faculty of Medicine. He earned his Ph.D. in Medicine from Kyoto University. His research centers on pediatric leukemia and tumor immunity, with additional focus in the areas of life sciences and tumor biology.
Kyoto University researchers identify 4MD biomarkers predicting CAR-T therapy success in blood cancers, advancing precision oncology in Japan.
Kyoto University team identifies CD38-CD73-Tim-3-HLA-DR+ biomarkers predicting CAR-T efficacy in BCP-ALL, advancing precision medicine at Japanese universities.